Literature DB >> 18554571

A novel mutation confirms MFRP as the gene causing the syndrome of nanophthalmos-renititis pigmentosa-foveoschisis-optic disk drusen.

Jaume Crespí1, José A Buil, Francisca Bassaganyas, José I Vela-Segarra, Jesús Díaz-Cascajosa, Raul Ayala-Ramírez, Juan C Zenteno.   

Abstract

PURPOSE: To describe the clinical and genetic characteristics of the second family with a recently described recessive syndrome characterized by posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disk drusen.
DESIGN: Observational case report.
METHODS: Three affected subjects and one healthy sibling from a consanguineous marriage from Spain were studied. Complete ophthalmologic examinations including A- and B-mode ultrasonography (US), electroretinography (ERG), fluorescein retinal angiography (FA), and optical coherence tomography (OCT) were performed in each individual. Genetic analysis included polymerase chain reaction amplification and direct nucleotide sequencing of the complete MFRP gene.
RESULTS: All three affected siblings had bilateral shortening of the posterior ocular segment associated with high hyperopia and normal anterior segment dimensions. Best-corrected visual acuity ranged from 20/200 to 20/60. Funduscopy, ERG, and FA were compatible with retinitis pigmentosa, and B-mode ultrasound showed optic disk drusen. OCT analysis revealed outer retinal layer schisis with absence of foveal pit. Inheritance of this syndrome followed an autosomal recessive pattern. Molecular analysis revealed a novel homozygous 1-bp deletion (c.498delC) in exon 5 of MFRP, predicting a prematurely truncated protein (P166fsX190). A healthy sister demonstrated to be a carrier of the mutation.
CONCLUSIONS: We confirmed that the syndrome of posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disk drusen constitutes a distinct autosomal recessive entity. The novel frameshift mutation identified in the family described here validates MFRP as the gene responsible for this particular disease, which characteristically involves structures located at the posterior segment of the eye.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554571     DOI: 10.1016/j.ajo.2008.04.029

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  42 in total

1.  Gene therapy for retinitis pigmentosa caused by MFRP mutations: human phenotype and preliminary proof of concept.

Authors:  Astra Dinculescu; Jackie Estreicher; Juan C Zenteno; Tomas S Aleman; Sharon B Schwartz; Wei Chieh Huang; Alejandro J Roman; Alexander Sumaroka; Qiuhong Li; Wen-Tao Deng; Seok-Hong Min; Vince A Chiodo; Andy Neeley; Xuan Liu; Xinhua Shu; Margarita Matias-Florentino; Beatriz Buentello-Volante; Sanford L Boye; Artur V Cideciyan; William W Hauswirth; Samuel G Jacobson
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

2.  174delG mutation in mouse MFRP causes photoreceptor degeneration and RPE atrophy.

Authors:  Joseph Fogerty; Joseph C Besharse
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-14       Impact factor: 4.799

3.  Genetic modifier loci of mouse Mfrp(rd6) identified by quantitative trait locus analysis.

Authors:  Jungyeon Won; Jeremy R Charette; Vivek M Philip; Timothy M Stearns; Weidong Zhang; Jürgen K Naggert; Mark P Krebs; Patsy M Nishina
Journal:  Exp Eye Res       Date:  2013-11-04       Impact factor: 3.467

4.  Clinical utility gene card for: Non-Syndromic Microphthalmia Including Next-Generation Sequencing-Based Approaches.

Authors:  Rose Richardson; Jane Sowden; Christina Gerth-Kahlert; Anthony T Moore; Mariya Moosajee
Journal:  Eur J Hum Genet       Date:  2017-01-18       Impact factor: 4.246

5.  Long-Term Effects of Gene Therapy in a Novel Mouse Model of Human MFRP-Associated Retinopathy.

Authors:  Anil Chekuri; Bhubanananda Sahu; Venkata Ramana Murthy Chavali; Marina Voronchikhina; Angel Soto-Hermida; John J Suk; Akhila N Alapati; Dirk-Uwe Bartsch; Raul Ayala-Ramirez; Juan C Zenteno; Astra Dinculescu; Monica M Jablonski; Shyamanga Borooah; Radha Ayyagari
Journal:  Hum Gene Ther       Date:  2019-01-16       Impact factor: 5.695

6.  Posterior microphthalmos pigmentary retinopathy syndrome.

Authors:  Niranjan Pehere; Subhadra Jalali; Himanshu Deshmukh; Chitra Kannabiran
Journal:  Doc Ophthalmol       Date:  2011-03-18       Impact factor: 2.379

7.  High-hyperopia database, part I: clinical characterisation including morphometric (biometric) differentiation of posterior microphthalmos from nanophthalmos.

Authors:  N Relhan; S Jalali; N Pehre; H L Rao; U Manusani; L Bodduluri
Journal:  Eye (Lond)       Date:  2015-10-23       Impact factor: 3.775

8.  A detailed phenotypic assessment of individuals affected by MFRP-related oculopathy.

Authors:  Rajarshi Mukhopadhyay; Panagiotis I Sergouniotis; Donna S Mackay; Alexander C Day; Genevieve Wright; Sophie Devery; Bart P Leroy; Anthony G Robson; Graham E Holder; Zheng Li; Andrew R Webster
Journal:  Mol Vis       Date:  2010-03-26       Impact factor: 2.367

9.  Evaluation of MFRP as a candidate gene for high hyperopia.

Authors:  Panfeng Wang; Zhikuan Yang; Shiqiang Li; Xueshan Xiao; Xiangming Guo; Qingjiong Zhang
Journal:  Mol Vis       Date:  2009-01-23       Impact factor: 2.367

10.  Compound heterozygosity for a novel and a recurrent MFRP gene mutation in a family with the nanophthalmos-retinitis pigmentosa complex.

Authors:  Juan Carlos Zenteno; Beatriz Buentello-Volante; Miguel A Quiroz-González; Miguel A Quiroz-Reyes
Journal:  Mol Vis       Date:  2009-09-05       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.